Novartis AG annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Novartis AG Operating Margin Growth & History (NVS)
Novartis AG's operating margin was 32.36% for fiscal 2025.
View full Novartis AG company overviewNovartis AG annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 32.36% | +3.45 pp |
| 2024 | 2024-12-31 | 28.90% | +7.41 pp |
| 2023 | 2023-12-31 | 21.50% | +2.67 pp |
| 2022 | 2022-12-31 | 18.83% | −4.68 pp |
| 2021 | 2021-12-31 | 23.51% | +2.64 pp |
| 2020 | 2020-12-31 | 20.86% | +1.73 pp |
| 2019 | 2019-12-31 | 19.13% | +0.39 pp |
| 2018 | 2018-12-31 | 18.74% | −1.79 pp |
| 2017 | 2017-12-31 | 20.53% | +3.49 pp |
| 2016 | 2016-12-31 | 17.04% | — |
Novartis AG quarterly operating margin
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 31.77% | −2.84 pp |
| Q1 2026 | 2026-03-31 | 31.31% | — |
| Q4 2025 | 2025-12-31 | 26.09% | — |
| Q3 2025 | 2025-09-30 | 31.35% | — |
| Q2 2025 | 2025-06-30 | 34.61% | +2.53 pp |
| Q2 2024 | 2024-06-30 | 32.08% | +7.54 pp |
| Q2 2023 | 2023-06-30 | 24.54% | +7.11 pp |
| Q2 2022 | 2022-06-30 | 17.43% | −9.42 pp |
| Q2 2021 | 2021-06-30 | 26.85% | +6.12 pp |
| Q2 2020 | 2020-06-30 | 20.73% | −1.91 pp |
| Q2 2019 | 2019-06-30 | 22.64% | +1.24 pp |
| Q2 2018 | 2018-06-30 | 21.40% | +2.78 pp |
| Q2 2017 | 2017-06-30 | 18.62% | — |
Novartis AG operating margin trends
Over the last five fiscal years, Novartis AG's operating margin increased from 20.86% to 32.36%, a change of +11.49 percentage points. The latest reported quarter, Q2 2026, shows 31.77%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novartis AG source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...
